Low transaortic flow rate was an independent predictor of 1-year all-cause mortality (HR 2.38; 95% CI 1.19 to 4.76, p=0.014) in patients with symptomatic low-gradient severe aortic stenosis.
Cohort (n=475)
Yes
Does low transaortic flow rate predict 1-year mortality better than ejection fraction and stroke volume index in patients with symptomatic low-gradient severe aortic stenosis undergoing TAVR?
In patients with symptomatic low-gradient severe aortic stenosis undergoing TAVR, low transaortic flow rate is an independent predictor of 1-year mortality, outperforming traditional volume-based metrics like LVEF and SVI.
Effect estimate: HR 2.38 (95% CI 1.19 to 4.76)
p-value: p=0.014
Background In low-gradient severe aortic stenosis (AS), reduced left ventricular ejection fraction (LVEF <50%) is practically used to define low flow and prompt dobutamine stress echocardiography to discern pseudo-severe AS. In patients with preserved LVEF, stroke volume index (SVI) <35 mL/m² is typically used. However, both are volume-based surrogates. Transaortic flow rate (TAFR), calculated as stroke volume divided by left ventricular ejection time, may better reflect true flow. Nonetheless, comparative data between TAFR and established metrics remain limited. We aimed to evaluate the prognostic value of TAFR in symptomatic low-gradient severe AS. Methods We retrospectively identified patients with low-gradient severe AS (AVA ≤1 cm 2 and peak velocity (Vmax) <4 m/s or mean gradient (MG) <40 mm Hg) who underwent transcatheter aortic valve replacement at Mayo Clinic sites (2017–2023). The primary outcome was 1-year all-cause mortality. Survival was assessed using Kaplan-Meier and Cox proportional hazards models. Results Among 475 patients included (mean age 85±8 years; 49% women), 242 (51%) had TAFR <220 mL/s, 165 (35%) had EF <50%, and 221 (47%) had SVI <35 mL/m 2 . Low TAFR was significantly associated with higher 1-year mortality even after stratifying by EF or SVI. In multivariate analysis, TAFR was an independent predictor of mortality (HR 2.38; 95% CI 1.19 to 4.76, p=0.014) after adjusting for reduced LVEF, low SVI, gender, chronic kidney disease and mitral and tricuspid regurgitation. Conclusions In patients with symptomatic low-gradient severe AS, low TAFR, not SVI or LVEF, is independently associated with mortality and may offer more accurate measure of flow state for clinical staging.
Allam et al. (2026) conducted a cohort in symptomatic low-gradient severe aortic stenosis (n=475). Transaortic flow rate (TAFR) vs. Ejection fraction and stroke volume index was evaluated on 1-year all-cause mortality (HR 2.38, 95% CI 1.19 to 4.76, p=0.014). Low transaortic flow rate was an independent predictor of 1-year all-cause mortality (HR 2.38; 95% CI 1.19 to 4.76, p=0.014) in patients with symptomatic low-gradient severe aortic stenosis.